153 related articles for article (PubMed ID: 25051916)
1. N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.
Yu J; Deng Y; Chen JP
Tumour Biol; 2014 Jul; 35(7):6861-5. PubMed ID: 25051916
[TBL] [Abstract][Full Text] [Related]
2. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
Wu H; Wang X; Zhang L; Mo N; Lv Z
Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
[TBL] [Abstract][Full Text] [Related]
3. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
[TBL] [Abstract][Full Text] [Related]
4. N-Acetyltransferase 2 (NAT2) genetic variation and the susceptibility to noncardiac gastric adenocarcinoma in Taiwan.
Chang CH; Huang YS; Perng CL; Lin HC
J Chin Med Assoc; 2016 Mar; 79(3):105-10. PubMed ID: 26617241
[TBL] [Abstract][Full Text] [Related]
5. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans.
Zhang YW; Eom SY; Kim YD; Song YJ; Yun HY; Park JS; Youn SJ; Kim BS; Kim H; Hein DW
Int J Cancer; 2009 Jul; 125(1):139-45. PubMed ID: 19350634
[TBL] [Abstract][Full Text] [Related]
7. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
[TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
[TBL] [Abstract][Full Text] [Related]
9. NAT2 slow acetylation genotypes contribute to asthma risk among Caucasians: evidence from 946 cases and 1,091 controls.
Wang Y; Zhang Q; Zhang M; Wang C
Mol Biol Rep; 2014 Mar; 41(3):1849-55. PubMed ID: 24442317
[TBL] [Abstract][Full Text] [Related]
10. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
11. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
12. Association of slow acetylation profile of NAT2 with breast and gastric cancer risk in Brazil.
Fernandes MR; de Carvalho DC; dos Santos ÂK; dos Santos SE; de Assumpção PP; Burbano RM; dos Santos NP
Anticancer Res; 2013 Sep; 33(9):3683-9. PubMed ID: 24023296
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
Hara A; Taira N; Mizoo T; Nishiyama K; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Miyoshi S
Breast Cancer; 2017 Mar; 24(2):254-262. PubMed ID: 27068825
[TBL] [Abstract][Full Text] [Related]
15. Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma.
Zhang J; Xu F; Ouyang C
Tumour Biol; 2012 Aug; 33(4):1059-63. PubMed ID: 22293947
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
Majumder M; Ghosh S; Roy B
Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
[TBL] [Abstract][Full Text] [Related]
17. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
[TBL] [Abstract][Full Text] [Related]
18. NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.
Wei Z; Zhang M; Zhang X; Yi M; Xia X; Fang X
PLoS One; 2019; 14(12):e0227043. PubMed ID: 31881062
[TBL] [Abstract][Full Text] [Related]
19. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
[TBL] [Abstract][Full Text] [Related]
20. Association between N-acetyltransferase 2 polymorphisms and pancreatic cancer risk: a meta-analysis.
Liang JX; Gao W; Liang Y; Zhou XM
Genet Mol Res; 2015 Dec; 14(4):17219-27. PubMed ID: 26681215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
